BRIEF published on 03/02/2026 at 11:40, 8 months 6 days ago O3 Holding GmbH publie son rapport intermédiaire du quatrième trimestre 2025 Résultats Financiers Emission D'obligations O3 Holding GmbH Groupe KD Pharma Rapport Intermédiaire Du Quatrième Trimestre 2025
PRESS RELEASE published on 03/02/2026 at 11:35, 8 months 6 days ago EQS-Adhoc: O3 Holding GmbH: O3 Holding GmbH - Publication Q4 2025 Interim Report O3 Holding GmbH, the holding company of KD Pharma Group, releases the Q4 2025 Interim Report as per bond terms. For more information, visit the company's investor relations webpage Financial Results Interim Report Q4 2025 O3 Holding GmbH KD Pharma Group
BRIEF published on 01/02/2026 at 08:35, 10 months 6 days ago O3 Holding GmbH Acquires Food-Grade Oil Business from dsm-firmenich Acquisition Dsm-firmenich O3 Holding GmbH Food-grade Oil KD Pharma Group
BRIEF published on 01/02/2026 at 08:35, 10 months 6 days ago O3 Holding GmbH acquiert l'activité d'huiles alimentaires de dsm-firmenich Acquisition Dsm-firmenich O3 Holding GmbH Huile De Qualité Alimentaire Groupe KD Pharma
PRESS RELEASE published on 01/02/2026 at 08:30, 10 months 6 days ago EQS-Adhoc: O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm- firmenich financed through shareholder loan O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm-firmenich through shareholder loan. Transaction closing today Acquisition Shareholder Loan O3 Holding GmbH Food-grade Oil KD Pharma Group
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:00, 15 minutes ago Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 15 minutes ago Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 20 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours 4 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 20 hours 59 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/09/2026 at 07:00, 15 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 15 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 15 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 15 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
